Use UniProt P14842 as the stable identity anchor, then attach disease evidence before program review.
CHEMBL322 Target Snapshot
5-hydroxytryptamine receptor 2A · SINGLE PROTEIN · Rattus norvegicus
Research home keeps recent targets
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Switch target
Move to another high-traffic target or paste a specific ChEMBL target ID.
Frame the target before identity details
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-13Protein identity stays anchored to UniProt P14842. Use UniProt P14842 as the stable identity anchor, then attach disease evidence before program review.
5-hydroxytryptamine receptor 2A
Review this target as 5-hydroxytryptamine receptor 2A, mapped to UniProt P14842. Sequence length is 471 aa.
Protein source · UniProt accession via ChEMBL component mappingCross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats 5-hydroxytryptamine receptor 2A as ChEMBL target CHEMBL322, mapped to UniProt P14842. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Start with the right source
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether 5-hydroxytryptamine receptor 2A is the right protein anchor across sources, using UniProt P14842 as the stable mapping.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardBasic Information
Verify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | 5-hydroxytryptamine receptor 2A |
| Target Type | SINGLE PROTEIN |
| Organism | Rattus norvegicus |
| UniProt | P14842 |
Next Actions
UniProt Target Context
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | 5-hydroxytryptamine receptor 2A |
| UniProt Accession | P14842 |
| Component Type | Protein |
| Sequence Length | 471 aa |
5-hydroxytryptamine receptor 2A
How to read this target
Review this target as 5-hydroxytryptamine receptor 2A, mapped to UniProt P14842. Sequence length is 471 aa.
Clinical Phase Distribution
Activity Type Distribution
Top Inhibitors (by pChEMBL)
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL3763812 | 10.9 | Ki | 0.0126 | Preclinical |
| CHEMBL1927096 | 10.79 | Ki | 0.0161 | Preclinical |
| CHEMBL1927096 | 10.66 | IC50 | 0.0217 | Preclinical |
| CHEMBL4205290 | 10.65 | Ki | 0.0224 | Preclinical |
| CHEMBL3763474 | 10.41 | Ki | 0.039 | Preclinical |
| CHEMBL3617113 | 10.37 | Ki | 0.043 | Preclinical |
| CHEMBL3765231 | 10.34 | Ki | 0.046 | Preclinical |
| CHEMBL83894 | 10.22 | Ki | 0.06 | Clinical |
| CHEMBL74355 | 10.0 | Ki | 0.1 | Clinical |
| CHEMBL6607 | 10.0 | Ki | 0.1 | Clinical |
pChEMBL Value Distribution
Approved Drugs
Assay Landscape
Binding — 344 assays, 2,054 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| single protein format | 106 | 384 | 7.2 |
| assay format | 89 | 651 | 7.1 |
| tissue-based format | 77 | 584 | 7.3 |
| cell membrane format | 43 | 241 | 7.0 |
| cell-based format | 26 | 194 | 7.5 |
| organism-based format | 3 | 0 | — |
Functional — 60 assays, 168 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| assay format | 23 | 33 | 6.4 |
| tissue-based format | 21 | 86 | 7.8 |
| cell-based format | 15 | 49 | 7.0 |
| organism-based format | 1 | 0 | — |
ADME — 3 assays, 2 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| cell-based format | 2 | 1 | 7.2 |
| tissue-based format | 1 | 1 | 5.7 |